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Abstract: Mitochondrial DNA (mtDNA) mutations accumulate in somatic stem cells during ageing
and cause mitochondrial dysfunction. In this review, we summarize the studies that link mtDNA
mutations to stem cell ageing. We discuss the age-related behaviours of the somatic mtDNA
mutations in stem cell populations and how they potentially contribute to stem cell ageing by
altering mitochondrial properties in humans and in mtDNA-mutator mice. We also draw attention
to the diverse fates of the mtDNA mutations with different origins during ageing, with potential
selective pressures on the germline inherited but not the somatic mtDNA mutations.
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1. Introduction
Ageing is a process where tissue gradually loses homeostasis and regeneration [1]. This process
is systemic and closely associated to age-related changes in somatic stem cells [2]. These cells renew
themselves and differentiate into tissue-specific daughter cells for tissue maintenance and regeneration.
The age-related alterations in somatic stem cell properties include failure to generate functional
progenies, depletion of the stem cell pool and cancerous transformation [3]. These changes largely
affect mitotic tissue, such as blood, intestine and skin, where the stem cells actively produce progenies
to maintain the high turnover of the tissue [4,5]. However, they also contribute to ageing post-mitotic
tissue, such as brain and muscle, though stem cells in these tissues are considered quiescent under
normal physiological conditions and activated in response to damage for repairing the tissue [6,7].
Mitochondria synthesize ATP via oxidative phosphorylation (OXPHOS) through five multi-subunit
complexes. Mitochondria contain their own DNA (mtDNA), which encodes key subunits of these
complexes. Replication of the mitochondrial genome is independent of the cell cycle [8]. In addition,
mtDNA is susceptible to damage due to lack of histone protection and proximity to oxidative stress [9].
Due to these reasons, compared with the nuclear DNA, mtDNA is more prone to mutations. Multiple
copies of mtDNA reside in a cell. Mutations of mtDNA usually occur as a proportion of the total copies
and once they reach a threshold, mitochondria will display respiratory chain deficiency, a consequence
of which is potentially excessive production of reactive oxygen species (ROS) [10]. mtDNA is maternally
transmitted through germline with a bottleneck effect, where only a small portion of mtDNA molecules
are distributed into each primordial germ cell, which are amplified in later oogenesis. As a result, mature
oocytes may have very different levels of mtDNA mutations [11].
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Ageing is accompanied by a reduction of mitochondrial function, resulting in respiratory chain
defects which are thought to be associated with the accumulation of somatic mtDNA mutations [12].
The age-related change in mitochondria may in turn accelerate the ageing process [13]. Although
the significance of mtDNA mutations in various parenchymal cells in normal ageing and age-related
degenerative diseases has been broadly studied [14], the findings might not be able to be extrapolated
to stem cells, as they are distinct from somatic cells in terms of biological and metabolic characteristics.
With an increasing amount of research linking mtDNA mutations to stem cell ageing in the last decade,
we discuss how the somatic mtDNA mutations behave during ageing in stem cell populations and
how they potentially influence phenotypes of the stem cells with the evidence from the recent studies.
Specifically, we want to draw attention to an intriguing age-related phenomenon of the germline
inherited mtDNA mutations in patients with mitochondrial disorders, as opposed to the accumulated
somatic mtDNA mutations in normal individuals, as mtDNA mutations from different origins seem to
have diverse fates with age.
2. Somatic mtDNA Mutations in Normal Ageing Humans
Respiratory chain defects have been observed in a variety of tissues in normal ageing humans,
including the tissue traditionally considered post-mitotic, such as skeletal muscle [15], heart [16] and
brain [17]; tissue with substantial mitotic potential after injury, for example, the liver [18]; as well
as the typical mitotic tissue such as the epithelium of the stomach [19], small intestine [20] and
colon (Figure 1) [21,22]. Various somatic mtDNA mutations were found to clonally expand and
accumulate to high levels with age in the respiratory chain deficient areas of the tissue, regardless of
their pathogenicity [21,23–27]. In addition, Shin et al. found increased mtDNA heterogeneity in CD34+
marked haematopoietic stem cell (HSC) and the progenitor cells both in the bone marrow and the
peripheral blood from the adult donors compared to the homogenous umbilical cord blood [26,28].
In the intestinal crypt where all the cells derive from the stem cells located at the base of the crypt, the
same somatic mtDNA mutation was determined at different regions along the OXPHOS defective
crypt, indicating that they originated from a communal stem cell that harboured the mutation [20].
Monoclonal conversion where a single stem cell with the accumulated somatic mtDNA mutation passes
the mutation to its progenies to occupy the entire crypt has also been observed in the stomach [19].
These studies provide robust evidence that in mitotic tissue, the accumulation of the somatic mtDNA
mutation during ageing initiates in stem cells. However, whether the mutations aggregate in the stem
cell of post-mitotic tissue, such as neural stem cells and satellite cells (muscle stem cell) and how they
influence the fate of their progenies in aged humans remains unclear.
The accumulation of the somatic mtDNA mutation during ageing can be entirely achieved by
random genetic drift, which takes place early in life in contrast to the damage to mtDNA by excessive
ROS production from the respiratory chain defect [29]. The pathogenicity of the acquired mtDNA
mutations is markedly higher than in germline variants, suggesting that the purifying selective
mechanism against germline mtDNA mutations is absent from the somatic mtDNA mutations [30].
The occurrence and the spread of the somatic mtDNA mutations during ageing are notably
tissue-specific, potentially influenced by the mitotic capability of the tissue. In contrast to miscellaneous
mtDNA point mutations found in the colonic stem cell populations, no large-scale deletions have been
detected in any OXPHOS deficient crypts [21]. Post-mitotic brain and muscle preferentially accumulate
mtDNA deletions instead of point mutations with age [31,32]. It has been proposed that neurons,
which are highly energy consuming and sensitive to ROS, tend to acquire mtDNA deletions during
the process of repairing the mtDNA that are injured by ROS [33]. Whereas in mitotic tissue, mtDNA
mutations are likely to arise from errors during replication [31]. Furthermore, the stem cell niche is
involved in dispersing the somatic mtDNA mutations specifically in mitotic tissue during ageing.
Gland and crypt fission from the stem cell niche in the stomach and colon, respectively, have been
shown to spread the mutation from a single unit to form a patch [19,34].
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Figure 1. Immunofluorescence images of the respiratory chain deficiency caused by the age-dependent
accumulation of somatic mitochondrial DNA (mtDNA) mutations in the colon. Respiratory chain
complex IV (marked by the COX1 antibody) is encoded by both mtDNA and nuclear DNA (nDNA),
which is affected by the increased burden of mtDNA mutations. Complex II (labelled by the SDHA
antibody) is entirely encoded by nDNA. The complex IV deficient colonic cells are indicated red in
the merged picture. COX1, a key subunit of complex IV encoded by mtDNA. SDHA, one of the four
nuclear encoded subunits of complex II. Scale bar: 50 µm.
However, limited numbers of human studies delve into how somatic mtDNA mutations affect
the function of stem cells and their progenies to contribute to the ageing phenotype of the tissue,
and the findings are controversial. Respiratory chain deficiency due to accumulated somatic mtDNA
mutations in colonic stem cells diminished the cell population of the crypt by weakening the cell
proliferation and enhancing the apoptosis of the stem cell progenies [35]. In contrast, the level of the
lineage markers labelling all the differentiated daughter cells derived from the OXPHOS deficient stem
cell were shown to be normal when compared to OXPHOS normal epithelium of the gastric unit and
the small intestinal crypt, indicating that the functionality of the progenies were not affected [19,20].
Additionally, the patch of hepatic progenitor cells and their descendants with OXPHOS defects did not
show any synthetic, metabolic or proliferative impairment [18]. Due to restricted sources of human
tissue samples, difficulties in tracing the stem cell dynamic condition in humans, and shortage of the
stem cell markers, the mechanism by which somatic mtDNA mutations influence stem cell ageing still
remains unknown in humans, and scientists have pursued animal models for investigation.
3. Ageing of Somatic Stem Cell Populations in mtDNA-Mutator Mice
The development of an mtDNA-mutator mouse model highlights the potentially important role of
somatic mtDNA mutations in ageing. These mice carry a knock-in mutation in the exonuclease domain
of the mtDNA polymerase γ (Polg), compromising the proofreading ability of Polg, which results in
an accumulation of mtDNA mutations with age [36,37]. The mutant mice have a shortened lifespan
and display a series of progeroid phenotypes, such as weight loss, kyphosis, hair greying and loss,
impaired hearing, thin subcutaneous fat, osteoporosis, sarcopenia and sterility, which mimics the signs
of normal human ageing [36,37]. In addition, the development of mitotic tissue including intestine,
thymus and testicle, is largely affected in the mutant mice [37]. Mutator mice suffer progressive
anaemia due to defective haematopoiesis, which is the main cause of death [36–38]. These findings
provide evidence that links the accumulation of somatic mtDNA mutations to stem cell ageing.
3.1. Age-Dependent Dysfunction of Stem Cells and Their Progenitors in Mitotic Tissue
The age-dependent accumulation of the somatic mtDNA mutations in the mtDNA-mutator
mice either alters the properties of stem cells per se or the downstream progenitors. Studies initially
focused on the haematopoietic system, which is a well-established model for stem cell research.
Reports show that the mice suffer from abnormal haematopoiesis for both erythroid and lymphoid
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lineage [38–40] and that this consequence caused by the mtDNA mutation in the haematopoietic
component is intrinsic, as transplanting the bone marrow from the homozygous mutants to the
wildtype mice recapitulates the mutant phenotype [38]. Different stages of the progenitor cells through
haematopoiesis have been shown to be more perturbed than the HSCs. However, HSCs themselves
show notably compromised ability for repopulation and self-renewal after serial transplantation [39].
In addition, studies show that the development of the haematopoietic system is dysregulated during
embryogenesis in the mtDNA mutator mice [40]. Intestinal epithelium is another beneficial model
for somatic stem cell research as it allows us to visualise the gradual cradle-to-grave manifestations
of the stem cell progenies in a straightforward fashion. Research on the small intestinal epithelium
of the mutant mice reveals abnormal cell proliferation and increased apoptosis in the Lieberkühn
crypt, where intestinal stem cells (ISC) and transit-amplifying cells are located [41]. Furthermore, the
organoids consisting of ISCs and Paneth cells derived from the isolated crypts of the mutants did
not grow efficiently in vitro [41]. These alterations resulted in prolonged cell migration and swollen
morphology of the intestinal epithelium, leading to impaired fat absorption of the mtDNA mutator
mice [41]. Studies have shown that, as with humans, the mtDNA mutations accumulating in the
colonic crypts of the heterozygous mutator mice randomly distribute through the mitochondrial
genome with no advantageous selection towards pathogenic mutations [42]. The clonal expansion of
the mutations can be simulated by the model of random genetic drift [42]. In contrast, there is a strong
rapid negative selection against nonsynonymous mtDNA mutations in the protein-coding regions
through germline transmission [11,43], underlining the difference in the mechanisms of the selection
during ageing and germline transmission.
3.2. Ageing of Progenitor Cells in Post-Mitotic Tissue
Compared to the severe symptoms due to mtDNA mutations in blood and other mitotic tissue,
post-mitotic tissue seems less affected by mtDNA mutagenesis in the mtDNA mutator mice. Although
respiratory chain function is preserved in the cerebrum, cerebellum and skeletal muscles, studies have
shown direct alterations in the homeostasis of neural stem cells and muscle progenitors [40,44].
The number of the nestin-positive neuronal stem cells was decreased in the OXPHOS deficient
subventricular zone of the adult mtDNA mutator mice, although the number of neurons was
normal [40]. Neural stem cells (NSC) isolated from the embryos of the mutator mice showed strikingly
reduced self-renewal ability, primarily because of the mtDNA mutagenesis, but not the secondary ROS,
as these cells accumulated high levels of mtDNA point mutations, while barely showing respiratory
chain deficiency [40]. Cardiac progenitor cells (CPC) isolated from the mtDNA mutator mice displayed
attenuated proliferation and higher inclination to death [44]. Mutagenesis of mtDNA also blocked the
metabolic transition of the mutant CPCs from glycolysis to OXPHOS as they differentiated, resulting in
a massive cell death through differentiation [44]. Furthermore, myoblasts extracted from the mtDNA
mutator mice were found to generate thinner myotubes in skeletal muscles [44]. These findings have
underlined the functional change in somatic stem cells and precursors in the post-mitotic tissue due to
age-related mtDNA mutagenesis.
4. Potential Mechanism Whereby Age-Related mtDNA Mutagenesis Affects Somatic Stem Cells
ROS is crucial for stem cell maintenance and is involved in manipulating stem cell differentiation,
though too much ROS may be detrimental [45,46]. Mitochondrial DNA mutations are traditionally
thought to affect the respiratory chain function of mitochondria, the main endogenous source of ROS,
and interfere stem cell homeostasis [47]. The free radical theory of ageing based on mitochondria was
initially proposed by Harman, where defective respiratory chain generates excessive ROS, damaging
mtDNA and engendering somatic mtDNA mutagenesis with age, which further causes increased
oxidative stress, forming a vicious cycle [48]. This theory was challenged when no obvious ROS
elevation was found in different tissues of the mtDNA-mutator mice [37,49]. Analogous findings have
been reported also in somatic stem cells [39]. However, treatment of antioxidant N-acetyl-L-cysteine
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(NAC) could rescue the impaired self-renewal ability of NSCs and abnormal haematopoiesis in the
mutator mice [40]. The exact mechanism underlying these contradictory findings is as yet unknown.
Despite an off-target possibility of NAC [50], these findings suggest that mtDNA mutagenesis may
slightly alter the ROS/redox level (Figure 2), which is able to imbalance the quiescence and regeneration
of the somatic stem cells [40]. This tiny change in the ROS/redox level might be insufficient to
be detected, but it can be neutralized by NAC. However, the effect of the NAC on the stem cell
population only seems to be effective if given during embryogenesis [40]. Of note, whether the
effect of the antioxidant on the somatic stem cell benefits alleviating the ageing phenotype of either
the stem cell or the tissue of the mutator mice remains controversial, as long-term treatment of
NAC from embryogenesis did not rescue the aberrant erythropoiesis in the adult mutator mice [51].
In addition, calorie restriction, which reduces ROS and enhances antioxidative defence shows no effect
on ameliorating the ageing phenotype of the mutator mice [52].
Figure 2. Schematic diagram of how the mitochondrial abnormalities caused by the age-dependent
accumulation of somatic mtDNA mutations affect stem cell homeostasis in the mtDNA mutator mice.
Mitochondrial DNA mutagenesis causes minor changes in reactive oxygen species (ROS)/redox level,
which may alter stem cell identity (quiescence and regeneration). The somatic mtDNA mutation
increases apoptosis and also shifts the level of mitophagy/autophagy in the stem cell population
possibly through the loss of the mitochondrial membrane potential (MMP), which may eventually
engender stem cell/progenitor depletion and accelerate stem cell senescence. Mitochondrial DNA
mutagenesis imbalances mitochondrial dynamics towards fission independent of ATP production,
which can affect stem cell self-renewal and differentiation. The amassing of somatic mtDNA mutations
prevents stem cells from converting glycolysis to oxidative phosphorylation (OXPHOS) as they
differentiate, resulting in cell death and failure to produce progenies. Normal mitochondria are
coloured orange and dysfunctional mitochondria are in blue. Mutated mtDNA are red and the normal
mtDNA are blue.
Recently, studies have reported another pre-ageing mouse model established by induced
expression of mitochondrial-targeted endonuclease (Mito-Pstl) [53,54]. The main consequence
of the double strand breaks of the mtDNA caused by the induction in these mice was mtDNA
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depletion [53,54]. In addition, mtDNA deletions accumulated in the post-mitotic brain and heart, but
not in the lung and liver of these mice, though the expression of endonuclease was low in the brain
and muscle but very high in the liver and lung [54]. Mitotic tissue was preferentially affected, with
effects on the function of stem cells and progenitor cells. The differentiation of thymic progenitor cells
was blocked at an early stage, leading to thymus shrinkage in these mice [54]. Satellite cells were
lost in skeletal muscles of these mice, causing muscle wasting, but no change in the oxidative stress
was detected in the muscle [53]. In addition, in the mitotic tissue that mainly displayed the ageing
phenotype, no mtDNA depletion was found, implying that there might be another pathway that causes
ageing rather than the secondary ROS generation caused by mtDNA depletion [54]. Together with the
findings of the mtDNA-mutator mice, these observations suggest multi-factorial causes of ageing due
to mtDNA mutagenesis or damage. In the cell model with the induction of the mtDNA endonuclease,
elevated levels of ROS were detected, and this upregulated the ageing-related cell cycle arrest nuclear
signalling pathway. This can be corrected by antioxidant NAC [54]. The absence of detectable changes
in oxidative stress in either mtDNA-mutator mice or the Mito-Pstl mice is interesting, especially since
many of the effects are reversed by NAC.
Accumulation of somatic mtDNA mutations can also cause dramatic alterations in
mitochondrial dynamics, which is further able to perturb stem cell self-renewal and differentiation.
During differentiation of the CPCs from the mtDNA mutator mouse, mitochondria displayed a series
of abnormalities when compared to the WT mice, including imbalanced fusion and fission, reduced
membrane potential, and poor development of the mitochondrial microstructure [44]. Mitochondrial
dynamics can change mitochondrial morphology and regulate stem cell destiny by ROS signalling
independent of generating ATP by OXPHOS [55]. Hence, though no change has been found in the
ATP level in the stem cells from the mtDNA-mutator mice [39,41,44], the age-dependent accumulation
of mtDNA mutations may still be able to alter the fate of stem cells secondarily through anomalous
mitochondrial dynamics (Figure 2).
In addition, the age-related mutagenesis of somatic mtDNA may hamper stem cell metabolism
as they differentiate (Figure 2). Stem cells are naturally glycolytic, and actively suppress OXPHOS
to maintain quiescence. Differentiation of stem cells requires a metabolic transition from glycolysis
to OXPHOS to increase ATP production [45]. Somatic mtDNA mutations prohibited this metabolic
shift as CPCs differentiate, leading to substantial cell death [44]. This could also be the reason for the
blockage of the differentiation at different stages through the early erythropoiesis [39].
Furthermore, the quality control of mitochondria is perturbed in the stem cell population of
the mtDNA-mutator mice, which may contribute to stem cell senescence. Autophagy is crucial
for maintaining stem cell quiescence and stemness against ageing [56,57]. Studies have reported
upregulated mitophagy rates in the CPCs [44] and inhibited autophagy in the early erythroid
precursors of the mtDNA-mutator mice, the latter of which contributed to the malfunction of
erythropoiesis [58]. Moreover, a lowered mitochondrial membrane potential (MMP) has been found
in the HSCs, various haematopoietic progenitors, and the CPCs in the mtDNA-mutator mice [39,44],
which is associated with mitophagy activation [59]. These observations indicate that mtDNA
mutagenesis may affect stem cell function by interfering with the level of mitophagy/autophagy
(Figure 2). However, how exactly mitophagy/autophagy responds to mtDNA mutagenesis in stem
cells is uncertain, as the findings seem to be contradictory in different stem cell/progenitor populations.
Of note, the loss of the MMP also occurs during apoptosis [60]. Consistently, strikingly increased
apoptosis levels were found in the erythroid precursors and the ISC population (Figure 2) [39,41],
which may subsequently lead to the depletion of the stem cell/progenitors. Surprisingly, no change in
the apoptosis was observed in the HSC [39].
The effect of age-related mtDNA mutagenesis on somatic stem cell ageing seems highly
tissue-specific. For haematopoiesis, it primarily affects the differentiation of downstream progenitor
cells rather than HSCs themselves [39]. In contrast, it markedly affects NSCs but its impact fades
during differentiation [40].
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5. Behaviour of mtDNA Mutations Inherited through Germline with Age
mtDNA mutations from different origins seem to act differently with age, despite causing the
same biochemical defect [14]. Mitochondrial disorders are caused by mtDNA mutations inherited
through the germline or occurring during embryogenesis. As opposed to the acquired somatic mtDNA
mutations that accumulate in stem cell populations with age, some of the inherited mtDNA mutations
are lost in mitotic tissue over time. Pearson syndrome is a severe medical condition caused by a
single, large-scale mtDNA deletion affecting the bone marrow haematopoietic compartment and
causing pancytopenia in patients [61]. However, the anaemia and the vacuolated haematopoietic
precursors in the bone marrow can be rescued by an age-related loss of the deletion and patients may
subsequently develop Kearns-Sayer syndrome, which primarily affects post-mitotic tissue [62–64].
It has also been reported that the mutation level of the inherited m.3243A>G, the most common
mtDNA point mutation that causes mitochondrial disease, decreased in blood and various epithelial
tissues with age in patients and asymptomatic carriers [65–68]. The in silico simulation suggests that
the loss of the mutation occurs in HSCs [69]. In addition, in a recently-developed mouse model of
mitochondrial disease, the inherited m.5024C>T was lost in the blood of the mice with high mutation
levels with age [70]. These studies imply that these inherited mtDNA mutations seem to be selected
against in the stem cell population in contrast to the somatic mtDNA mutations, which are under
no selective pressures [30]. However, no observations of the negative selection have been reported
directly in stem cells in vivo, and the mechanism is as yet unexplored. Investigating the underlying
mechanism of the mtDNA mutation with different origins reacting differentially to age is crucial for
understanding both the process of normal ageing and development of the mitochondrial disease.
6. Conclusions
We have provided evidence of the somatic mtDNA mutations accumulating in stem cell
populations in normal humans and discussed their tissue-specific ability to expand clonally during
ageing. The premature ageing mtDNA-mutator mouse model gives insight into how acquired mtDNA
mutations affect the function of the stem cells and progenitors in both the mitotic and post-mitotic
tissue, as well as the potential mechanisms by which age-related mtDNA mutagenesis affects stem cell
homeostasis. We also highlight the intriguing contrast in the selective pressures against the mtDNA
mutation with different origins in the fast-renewing mitotic tissue. Stem cells, which are responsible for
tissue maintenance and regeneration, might be involved in the selective process against the inherited
mtDNA mutation. Recently, studies have reported that stem cells might actively regulate their identity
by manipulating the quality control of the mitochondria, for example, by removing the dysfunctional
mitochondria [56] or by unevenly segregating young and aged mitochondria [71]. The quality control
system might lose the function during ageing, leading to the absence of selective pressures on the
somatic mtDNA mutations, which in turn accelerates ageing. We believe that investigating the
mechanism of the difference in the selective pressure on the somatic and the inherited mtDNA
mutations has a profound influence on understanding the progress of normal ageing, ageing-related
degenerative diseases and cancer formation [72,73]. Studies have now provided several methods for
preventing the germline transmission of the inherited mtDNA mutations to enable producing healthy
children from affected mothers [74–76]. However, no efficacious interventions have been found for
diseases caused by mutations that occur during embryogenesis. Understanding the mechanism of the
selective pressure on the inborn mtDNA mutation will also propel the development of the treatment
for mitochondrial disorders, especially for those occurring during embryogenesis and those that are
recessive with late-onset.
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